tafenoquine has been researched along with bay h 4502 in 1 studies
| Studies (tafenoquine) | Trials (tafenoquine) | Recent Studies (post-2010) (tafenoquine) | Studies (bay h 4502) | Trials (bay h 4502) | Recent Studies (post-2010) (bay h 4502) |
|---|---|---|---|---|---|
| 186 | 37 | 113 | 305 | 49 | 67 |
| Protein | Taxonomy | tafenoquine (IC50) | bay h 4502 (IC50) |
|---|---|---|---|
| phospholipase A2 precursor | Homo sapiens (human) | 8.89 | |
| cysteine protease ATG4B isoform a | Homo sapiens (human) | 8.5 | |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Homo sapiens (human) | 0.79 | |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.342 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avery, VM; Sykes, ML | 1 |
1 review(s) available for tafenoquine and bay h 4502
| Article | Year |
|---|---|
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |